148 related articles for article (PubMed ID: 9774436)
1. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells.
Datta K; Biswal SS; Xu J; Towndrow KM; Feng X; Kehrer JP
J Biol Chem; 1998 Oct; 273(43):28163-9. PubMed ID: 9774436
[TBL] [Abstract][Full Text] [Related]
2. Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis.
Wu X; Biswal SS; Kehrer JP
Cell Biol Toxicol; 2003 Jun; 19(3):135-43. PubMed ID: 12945742
[TBL] [Abstract][Full Text] [Related]
3. Association between bcl-x(L) and 5-lipoxygenase activating protein (FLAP) levels in IL-3-dependent FL5.12 cells.
Biswal SS; Datta K; Kehrer JP
Toxicology; 2001 Mar; 160(1-3):97-103. PubMed ID: 11246129
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic loss of bcl-x(L) in FL5.12 Cells undergoing apoptosis induced by MK886.
Datta K; Kern JC; Biswal SS; Kehrer JP
Toxicol Appl Pharmacol; 2001 Aug; 174(3):273-81. PubMed ID: 11485388
[TBL] [Abstract][Full Text] [Related]
5. Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells.
Biswal SS; Datta K; Shaw SD; Feng X; Robertson JD; Kehrer JP
Toxicol Sci; 2000 Jan; 53(1):77-83. PubMed ID: 10653524
[TBL] [Abstract][Full Text] [Related]
6. The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP.
Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):371-5. PubMed ID: 10333477
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886.
Tong Z; Wu X; Kehrer JP
Biochem J; 2003 May; 372(Pt 1):203-10. PubMed ID: 12614196
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid release and oxidation are factors in lipoxygenase inhibitor-induced apoptosis.
La E; Kern JC; Atarod EB; Kehrer JP
Toxicol Lett; 2003 Mar; 138(3):193-203. PubMed ID: 12565196
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Magro AM; Magro AD; Cunningham C; Miller MR
Neoplasma; 2007; 54(6):517-26. PubMed ID: 17949236
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
Zhang XD; Gillespie SK; Borrow JM; Hersey P
Mol Cancer Ther; 2004 Apr; 3(4):425-35. PubMed ID: 15078986
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
12. Bcl-xL overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal.
Bojes HK; Datta K; Xu J; Chin A; Simonian P; Nuñez G; Kehrer JP
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):315-9. PubMed ID: 9230108
[TBL] [Abstract][Full Text] [Related]
13. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.
Anto RJ; Mukhopadhyay A; Denning K; Aggarwal BB
Carcinogenesis; 2002 Jan; 23(1):143-50. PubMed ID: 11756235
[TBL] [Abstract][Full Text] [Related]
14. Bcl-xL overexpression restricts heat-induced apoptosis and influences hsp70, bcl-2, and Bax protein levels in FL5.12 cells.
Robertson JD; Datta K; Kehrer JP
Biochem Biophys Res Commun; 1997 Dec; 241(1):164-8. PubMed ID: 9405251
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
16. Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis.
Robertson JD; Datta K; Biswal SS; Kehrer JP
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):477-85. PubMed ID: 10567231
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of N-acetylcysteine-driven enhancement of MK886-induced apoptosis.
Deshpande VS; Kehrer JP
Cell Biol Toxicol; 2006 Jul; 22(4):303-11. PubMed ID: 16817014
[TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
Lamothe B; Aggarwal BB
J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
